TLR4 and head and neck squamous cell carcinoma: For instance, loss‐of‐function polymorphisms in TLR4 or P2RX7 have been associated with poorer outcomes in breast and head and neck squamous cell carcinoma (HNSCC) patients receiving anthracycline‐based adjuvant CT [226, 227, 228].